81 related articles for article (PubMed ID: 26208667)
1. Evaluation of soluble interleukin-2 receptor and serum lactate dehydrogenase in malignant lymphoma.
Tomita N; Taguri M; Hashimoto C; Takasaki H; Fujimaki K; Motomura S; Koharazawa H; Takemura S; Fujita H; Yamazaki E; Kawasaki R; Taguchi J; Sakai R; Fujisawa S; Hattori Y; Kanamori H; Yamamoto W; Harano H; Ogawa K; Ishigatsubo Y
Ann Hematol; 2015 Nov; 94(11):1935-7. PubMed ID: 26208667
[No Abstract] [Full Text] [Related]
2. Serum soluble interleukin-2 receptor levels in patients with malignant lymphoma of bone.
Akahane T; Shimizu T; Isobe K; Yoshimura Y; Kato H
J Orthop Sci; 2009 May; 14(3):248-52. PubMed ID: 19499289
[TBL] [Abstract][Full Text] [Related]
3. Urinary pseudouridine in patients with lymphoma: comparison with other clinical parameters.
Masaki Y; Itoh K; Sawaki T; Karasawa H; Kawanami T; Fukushima T; Kawabata H; Wano Y; Hirose Y; Suzuki T; Sugai S; Umehara H
Clin Chim Acta; 2006 Sep; 371(1-2):148-51. PubMed ID: 16643879
[TBL] [Abstract][Full Text] [Related]
4. Serum thymidine kinase and soluble interleukin-2 receptor predict recurrence of malignant lymphoma.
Wakao D; Murohashi I; Tominaga K; Yoshida K; Kishimoto K; Yagasaki F; Itoh Y; Itoh K; Sakata T; Kawai N; Kayano H; Suzuki T; Matsuda A; Hirashima K; Bessho M
Ann Hematol; 2002 Mar; 81(3):140-6. PubMed ID: 11904739
[TBL] [Abstract][Full Text] [Related]
5. [Detection of soluble interleukin-2 receptor in the serum of patients with non-Hodgkin's lymphoma].
Pérez Encinas M; Bello JL; Bendaña A; Rabuñal MJ; González S; Abuín I; Noya M; Cadarso C
Med Clin (Barc); 1998 Jul; 111(5):161-7. PubMed ID: 9732831
[TBL] [Abstract][Full Text] [Related]
6. [Blood test for malignant lymphoma].
Kobayashi T; Kuroda J; Taniwaki M
Nihon Rinsho; 2014 Mar; 72(3):407-11. PubMed ID: 24724395
[TBL] [Abstract][Full Text] [Related]
7. Measurement and cellular sources of the soluble interleukin-2 receptor in primary central nervous system lymphoma.
Kitai R; Sasaki H; Matsuda K; Tsunetoshi K; Yamauchi T; Neishi H; Matsumura K; Tsunoda A; Takeuchi H; Sato K; Kikuta K
Brain Tumor Pathol; 2013 Jan; 30(1):34-9. PubMed ID: 22399193
[TBL] [Abstract][Full Text] [Related]
8. Serum lactate dehydrogenase with a systemic inflammation score is useful for predicting response and survival in patients with newly diagnosed diffuse large B-cell lymphoma.
Jung SH; Yang DH; Ahn JS; Kim YK; Kim HJ; Lee JJ
Acta Haematol; 2015; 133(1):10-7. PubMed ID: 24969101
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of serum soluble interleukin-2 receptor level in patients with non-Hodgkin's lymphoma].
Shimomura Y; Tsurumi H; Sawada M; Yamada T; Hara T; Fukuno K; Goto H; Moriwaki H
Rinsho Ketsueki; 1999 Aug; 40(8):639-45. PubMed ID: 10496038
[TBL] [Abstract][Full Text] [Related]
10. [Tumor markers in malignant lymphoma].
Banno S; Ueda R
Gan To Kagaku Ryoho; 2002 Jan; 29(1):149-53. PubMed ID: 11816473
[TBL] [Abstract][Full Text] [Related]
11. Biopsy of cervical lymph node.
Matsumoto F; Itoh S; Ohba S; Yokoi H; Furukawa M; Ikeda K
Auris Nasus Larynx; 2009 Feb; 36(1):71-4. PubMed ID: 18479855
[TBL] [Abstract][Full Text] [Related]
12. Soluble interleukin 2 receptors in patients with malignant lymphoma.
Harrington DS; Patil K; Lai PK; Yasuda NN; Armitage JO; Ip SH; Weisenburger DD; Linder J; Purtilo DT
Arch Pathol Lab Med; 1988 Jun; 112(6):597-601. PubMed ID: 2837161
[TBL] [Abstract][Full Text] [Related]
13. Increased serum concentration of the soluble interleukin-2 receptor in cutaneous T-cell lymphoma. Clinical and prognostic implications.
Wasik MA; Vonderheid EC; Bigler RD; Marti R; Lessin SR; Polansky M; Kadin ME
Arch Dermatol; 1996 Jan; 132(1):42-7. PubMed ID: 8546482
[TBL] [Abstract][Full Text] [Related]
14. Serum soluble interleukin 2 receptor in patients with IgA nephropathy.
Yorioka N; Hirabayashi A; Takemasa A; Kanahara K; Takahashi N; Oda H; Joarder ZH; Harada S; Yamakido M
Hiroshima J Med Sci; 1989 Dec; 38(4):169-71. PubMed ID: 2637244
[TBL] [Abstract][Full Text] [Related]
15. [Tumor markers in malignant lymphoma].
Kato H; Ogura M
Gan To Kagaku Ryoho; 2005 Jun; 32(6):883-92. PubMed ID: 15984537
[TBL] [Abstract][Full Text] [Related]
16. [Expression of plasma TNF-α and TNF-β in different subtypes lymphoma and its significance].
Halida Y; Guo XH; Aliya R
Zhonghua Xue Ye Xue Za Zhi; 2011 Oct; 32(10):695-7. PubMed ID: 22339832
[No Abstract] [Full Text] [Related]
17. Serum soluble interleukin-2 receptor, beta2-microglobulin, lactate dehydrogenase and erythrocyte sedimentation rate in children with Hodgkin's lymphoma.
Bien E; Balcerska A
Scand J Immunol; 2009 Nov; 70(5):490-500. PubMed ID: 19874554
[TBL] [Abstract][Full Text] [Related]
18. Elevated circulating soluble interleukin-2 receptor in patients with non-segmental vitiligo in North American.
Shi YL; Li K; Hamzavi I; Lim HW; Zhou L; Mi QS
J Dermatol Sci; 2013 Sep; 71(3):212-4. PubMed ID: 23870656
[No Abstract] [Full Text] [Related]
19. Serum levels of tumor necrosis factor and soluble interleukin 2 receptor as markers of disease activity and prognosis in childhood leukemia and lymphoma.
Kalmanti M; Karamolengou K; Dimitriou H; Tosca A; Vlachonikolis I; Peraki M; Georgoulias V; Kalmantis T
Int J Hematol; 1993 Apr; 57(2):147-52. PubMed ID: 8494993
[TBL] [Abstract][Full Text] [Related]
20. A case of vogt-koyanagi-harada disease associated with malignant lymphoma.
Hashida N; Kanayama S; Kawasaki A; Ogawa K
Jpn J Ophthalmol; 2005; 49(3):253-6. PubMed ID: 15944834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
